Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CCR1 and CCR5 mediate cancer-induced myelopoiesis and differentiation of myeloid cells in the tumor

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-003131Source: DataRank Database

CCR1 and CCR5 mediate cancer-induced myelopoiesis and differentiation of myeloid cells in the tumor is a research paper published in Journal for ImmunoTherapy of Cancer (2022). On theSindex it has a DataRank of 0. It has been cited 35 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access35 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)OA: goldTopics (35)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Silvio Bicciato ORCID,Donald T. Weed ORCID,Paolo Serafini ORCID,Serena Zilio ORCID

Live enrichment

PubMed:35064009 PMC:PMC8785210

U.S. Department of Defense

Grant: W81XWH-13-1-0186

NIH

Grant: P30CA240139

Associazione Italiana per la Ricerca sul Cancro

Grant: NA

NIH-NCI

Grant: R21CA263607-01

NCI NIH HHS

Grant: R21 CA263607

NIAID NIH HHS

Grant: R21 AI105320

National Institutes of Health

Grant: 5R21CA263607-02

Aptamer mediated silencing of the spliceosome machinery to increase the immunogenicity of metastatic breast cancer

National Institutes of Health

Grant: 3P30CA240139-02S3

The Sylvester Cancer Center Support Grant

goldLicense: cc-by

publisherhttps://jitc.bmj.com/content/jitc/10/1/e003131.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1136/jitc-2021-003131

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8785210

repositoryhttps://doaj.org/article/1e8e62bc645c438d9298ac4c6f3330d6

repositoryhttp://hdl.handle.net/11380/1281892

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsHumansMiceReceptors, CCR5Cell DifferentiationMyelopoiesisNanoparticlesReceptors, CCR1ImmunomodulationTumor MicroenvironmentMyeloid-Derived Suppressor Cells

Keywords

ReceptorsImmunomodulationAntigenImmunityInnateMyeloid-derived Suppressor CellsNeutrophil InfiltrationMyelopoiesisReceptors, CCR5Receptors, CCR1Neoplasms. Tumors. Oncology. Including cancer and carcinogensBasic Tumor ImmunologyCell Differentiationantigen; immunity; immunomodulation; innate; myeloid-derived suppressor cells; neutrophil infiltration; receptors; Animals; Cell Differentiation; Humans; Immunomodulation; Mice; Myeloid-Derived Suppressor Cells; Myelopoiesis; Nanoparticles; Receptors, CCR1; Receptors, CCR5; Tumor Microenvironmentantigen; immunity; immunomodulation; innate; myeloid-derived suppressor cells; neutrophil infiltration; receptorsMiceTumor MicroenvironmentAnimalsHumansNanoparticlesRC254-282

Sustainable Development Goals

SDG 3: 3. Good health

CCR1 and CCR5 mediate cancer-induced myelopoiesis and differentiation of myeloid cells in the tumor

FAIR Checklist

Authors (4)

Funding (8 grants)

Open Access

Topics

Annotations (Europe PMC)